Osteopenia and fractures associated with long-term therapy with MEK inhibitors.
Dumas M, Laly P, Gottlieb J, Vercellino L, Paycha F, Bagot M, Baroudjian B, Madelaine I, Basset-Seguin N, Eftekhari P, Pagès C, Lebbé C, Lioté F.
Dumas M, et al. Among authors: madelaine i.
Melanoma Res. 2018 Dec;28(6):641-644. doi: 10.1097/CMR.0000000000000490.
Melanoma Res. 2018.
PMID: 30124538